MicroVascular Therapeutics is a biotechnology company that develops contrast agents for molecular imaging and image-guided therapy... Read more
MicroVascular Therapeutics is a biotechnology company that develops contrast agents for molecular imaging and image-guided therapy... Read more
News
Nov 04, 2025
PRcom
Press Release: MVT : MVT Reports Breakthrough Preclinical Results for MVT101 in DVT Model
May 15, 2025
PRcom
Press Release: MVT : Microvascular Therapeutics: Positive Clinical Trial Results with Lead Candidate, CardiSon (MVT-100)
Sep 13, 2024
PRcom
Press Release: MVT : Microvascular Therapeutics Announce Completion of Phase 2 Study Enrollment for MVT-100
Dec 13, 2023
PRcom
Press Release: MVT : Microvascular Therapeutics Selected as a Participant in the 2023 H7 BioCapital Accelerator Program
Oct 18, 2023
PRcom
Press Release: MVT : Microvascular Therapeutics Receives $3.98M Award from Department of Defense for Its Cardiovascular Product
Apr 21, 2022
PRcom
Press Release: MVT : Microvascular Therapeutics Finalizes Facility Certification for the Production of Its Product, MVT-100
Apr 09, 2022
PRcom
Press Release: MVT : Microvascular Therapeutics Receives Funds from Commercialization Readiness Program for the Development of Its Ultrasound Contrast Agent, MVT-100
Jul 19, 2021
PRcom
Press Release: Micro Vascular Theraputics, LLC : Microvascular Therapeutics Has Received Funds from the National Heart, Lung and Blood Institute (NHLBI)
Aug 03, 2020
PRcom
Press Release: Micro Vascular Theraputics, LLC : Microvascular Therapeutics Receives NIH SBIR Phase I Funds for Its Alzheimer Program
Jul 31, 2020
PRcom
Press Release: Micro Vascular Theraputics, LLC : Microvascular Therapeutics Receives NIH SBIR Phase I Funds for Its Program to Treat Heart Attack
MVT Competitors
1
2
3
4